Continuous Glucose Monitoring Device Market on Track to Hit USD 54,735.48 million by 2032, Booming at 21.8% CAGR | Key Players- Glycens,Insulet Corporation, A. Menarini Diagnostics

𝐌𝐚𝐫𝐤𝐞𝐭 𝐎𝐮𝐭𝐥𝐨𝐨𝐤:

• The global continuous glucose monitoring device market was valued at USD 9277.16 million in 2023.
• The market is expected to expand at a CAGR of 21.8% from 2024 to 2032.
• The market is expected to grow to USD 54,735.48 million by 2032.

𝐎𝐯𝐞𝐫𝐯𝐢𝐞𝐰:

Continuous glucose monitoring (CGM) devices are medical tools that keep track of glucose levels in the body nonstop, around the clock. Typically, these systems include a small sensor inserted under the skin to monitor glucose levels every few minutes, a transmitter to send information to a display device, and a display device to visualize the data. CGMs are utilized for monitoring blood sugar levels and adjusting insulin or medication as necessary, assisting individuals with diabetes and other ailments. They can be utilized for identifying trends in blood sugar levels and notifying users of potential issues sooner.

𝐄𝐱𝐩𝐥𝐨𝐫𝐞 𝐭𝐡𝐞 𝐂𝐨𝐦𝐩𝐫𝐞𝐡𝐞𝐧𝐬𝐢𝐯𝐞 𝐒𝐚𝐦𝐩𝐥𝐞 𝐑𝐞𝐬𝐞𝐚𝐫𝐜𝐡 𝐀𝐧𝐚𝐥𝐲𝐬𝐢𝐬 𝐑𝐞𝐩𝐨𝐫𝐭 𝐇𝐞𝐫𝐞:
https://www.polarismarketresearch.com/industry-analysis/continuous-glucose-monitoring-market/request-for-sample

𝐆𝐫𝐨𝐰𝐭𝐡 𝐅𝐚𝐜𝐭𝐨𝐫𝐬 𝐚𝐧𝐝 𝐎𝐩𝐩𝐨𝐫𝐭𝐮𝐧𝐢𝐭𝐢𝐞𝐬:

Technological advancements play a crucial role in fueling the growth of the continuous glucose monitoring device market. Advancements in sensors and miniaturization have led to the development of more compact and comfortable devices, leading to improved patient adherence. Furthermore, the growing occurrence of diabetes on a worldwide scale is increasing the need for CGM devices. As the number of people with diabetes increases, the demand for continuous glucose monitoring is also rising in order to control the condition effectively.

𝐊𝐞𝐲 𝐏𝐚𝐫𝐭𝐢𝐜𝐢𝐩𝐚𝐧𝐭𝐬:

The market is marked by fierce competition, and the leading companies rely on innovative technology, superior goods, and a strong brand identity to boost sales. Some of the major players participating in the market are:
• A. Menarini Diagnostics
• Echo Therapeutics Inc.
• Abbott Laboratories
• Bayer AG
• Dexcom Inc.
• F. Hoffmann-La Roche Ltd.
• GE Healthcare
• Glycens
• GlySens Incorporated
• Insulet Corporation
• Johnson & Johnson
• LifeScan
• Medtronic plc
• Medtrum Technologies Inc.
• Microchip Technology Inc.
• Micron Technology Inc.

𝐈𝐧𝐪𝐮𝐢𝐫𝐞 𝐍𝐨𝐰 𝐟𝐨𝐫 𝐌𝐨𝐫𝐞 𝐈𝐧𝐟𝐨𝐫𝐦𝐚𝐭𝐢𝐨𝐧 𝐀𝐛𝐨𝐮𝐭 𝐓𝐡𝐢𝐬 𝐑𝐞𝐩𝐨𝐫𝐭 𝐁𝐞𝐟𝐨𝐫𝐞 𝐏𝐮𝐫𝐜𝐡𝐚𝐬𝐞:
https://www.polarismarketresearch.com/industry-analysis/continuous-glucose-monitoring-market/inquire-before-buying

𝐂𝐨𝐮𝐧𝐭𝐫𝐲-𝐖𝐢𝐬𝐞 𝐈𝐧𝐬𝐢𝐠𝐡𝐭𝐬:

• North America (U.S., Canada)
• Europe (France, Germany, UK, Italy, Netherlands, Spain, Russia)
• Asia Pacific (Japan, China, India, Malaysia, Indonesia, South Korea)
• Latin America (Brazil, Mexico, Argentina)
• Middle East & Africa (Saudi Arabia, UAE, Israel, South Africa)

𝐌𝐚𝐫𝐤𝐞𝐭 𝐒𝐞𝐠𝐦𝐞𝐧𝐭𝐚𝐭𝐢𝐨𝐧:

The continuous glucose monitoring device market is mainly segmented based on component type, end-use, and region. Based on the component type analysis, sensor segment in anticipated to witness significant growth in the near future owing to technological advancements that enable more accurate monitoring and the limited lifespan of sensors.

Moreover, according to the end-use analysis, home health testing is now the top segment and is projected to remain at the forefront throughout the projection period. It can be attributed to increasing convenience, awareness, higher disposable income, and ease of use.

𝐄𝐱𝐩𝐥𝐨𝐫𝐞 𝐭𝐡𝐞 𝐂𝐨𝐦𝐩𝐥𝐞𝐭𝐞 𝐂𝐨𝐦𝐩𝐫𝐞𝐡𝐞𝐧𝐬𝐢𝐯𝐞 𝐑𝐞𝐩𝐨𝐫𝐭 𝐇𝐞𝐫𝐞: https://www.polarismarketresearch.com/industry-analysis/continuous-glucose-monitoring-market

𝐂𝐨𝐧𝐭𝐢𝐧𝐮𝐨𝐮𝐬 𝐆𝐥𝐮𝐜𝐨𝐬𝐞 𝐌𝐨𝐧𝐢𝐭𝐨𝐫𝐢𝐧𝐠 𝐃𝐞𝐯𝐢𝐜𝐞 𝐌𝐚𝐫𝐤𝐞𝐭 𝐑𝐞𝐩𝐨𝐫𝐭 𝐇𝐢𝐠𝐡𝐥𝐢𝐠𝐡𝐭𝐬

• The sensor segment is anticipated to witness significant growth during the forecast period as technological advancements and the short lifespan of sensors are driving growth.
• Homecare diagnostics, the largest segment, is expected to maintain dominance due to awareness, convenience, rising income, and COVID-19 concerns in hospitals.
• North America is set to dominate the continuous glucose monitoring device market due to a high prevalence of diabetes and supportive factors.

𝐄𝐱𝐩𝐥𝐨𝐫𝐞 𝐏𝐌𝐑'𝐬 𝐄𝐱𝐭𝐞𝐧𝐬𝐢𝐯𝐞 𝐨𝐧𝐠𝐨𝐢𝐧𝐠 𝐂𝐨𝐯𝐞𝐫𝐚𝐠𝐞 𝐨𝐧 𝐇𝐞𝐚𝐥𝐭𝐡𝐜𝐚𝐫𝐞 𝐃𝐨𝐦𝐚𝐢𝐧:

Leukapheresis Market: https://www.polarismarketresearch.com/industry-analysis/leukapheresis-market

Mesotherapy Market: https://www.polarismarketresearch.com/industry-analysis/mesotherapy-market

Enteric Disease Testing Market: https://www.polarismarketresearch.com/industry-analysis/enteric-disease-testing-market

Speech Therapy Services Market: https://www.polarismarketresearch.com/industry-analysis/speech-therapy-services-market

Contact:
Likhil G
8 The Green Ste 19824,
Dover, DE 19901,
United States
Phone: +1-929 297-9727
Email: sales@polarismarketresearch.com
Web: https://www.polarismarketresearch.com
Follow Us: LinkedIn | Twitter

About Polaris Market Research & Consulting, Inc:

Polaris Market Research is a global market research and consulting company. The company specializes in providing exceptional market intelligence and in-depth business research services for PMR's clientele spread across different enterprises. We at Polaris are obliged to serve PMR's diverse customer base present across the industries of healthcare, technology, semiconductors, and chemicals among various other industries present around the world. We strive to provide PMR's customers with updated information on innovative technologies, high-growth markets, emerging business environments, and the latest business-centric applications, thereby helping them always to make informed decisions and leverage new opportunities. Adept with a highly competent, experienced, and extremely qualified team of experts comprising SMEs, analysts, and consultants, we at Polaris endeavor to deliver value-added business solutions to PMR's customers.

This release was published on openPR.